264 related articles for article (PubMed ID: 24904967)
21. Histone deacetylase inhibitor AR-42 and achiral analogues kill malaria parasites in vitro and in mice.
Chua MJ; Tng J; Hesping E; Fisher GM; Goodman CD; Skinner-Adams T; Do D; Lucke AJ; Reid RC; Fairlie DP; Andrews KT
Int J Parasitol Drugs Drug Resist; 2021 Dec; 17():118-127. PubMed ID: 34560571
[TBL] [Abstract][Full Text] [Related]
22. In vitro Multistage Malaria Transmission Blocking Activity of Selected Malaria Box Compounds.
Malebo HM; D'Alessandro S; Ebstie YA; Sorè H; Tenoh Guedoung AR; Katani SJ; Parapini S; Taramelli D; Habluetzel A
Drug Des Devel Ther; 2020; 14():1593-1607. PubMed ID: 32425505
[TBL] [Abstract][Full Text] [Related]
23. Small-molecule histone methyltransferase inhibitors display rapid antimalarial activity against all blood stage forms in Plasmodium falciparum.
Malmquist NA; Moss TA; Mecheri S; Scherf A; Fuchter MJ
Proc Natl Acad Sci U S A; 2012 Oct; 109(41):16708-13. PubMed ID: 23011794
[TBL] [Abstract][Full Text] [Related]
24. The structural requirements of histone deacetylase inhibitors: SAHA analogs modified at the C5 position display dual HDAC6/8 selectivity.
Negmeldin AT; Pflum MKH
Bioorg Med Chem Lett; 2017 Aug; 27(15):3254-3258. PubMed ID: 28648461
[TBL] [Abstract][Full Text] [Related]
25. Discovery of FNDR-20123, a histone deacetylase inhibitor for the treatment of Plasmodium falciparum malaria.
Potluri V; Shandil RK; Gavara R; Sambasivam G; Campo B; Wittlin S; Narayanan S
Malar J; 2020 Oct; 19(1):365. PubMed ID: 33046062
[TBL] [Abstract][Full Text] [Related]
26. Exploration of thiaheterocyclic hHDAC6 inhibitors as potential antiplasmodial agents.
Vreese R; Kock C; Smith PJ; Chibale K; D'hooghe M
Future Med Chem; 2017 Mar; 9(4):357-364. PubMed ID: 28263085
[TBL] [Abstract][Full Text] [Related]
27. Molecular cloning and nuclear localization of a histone deacetylase homologue in Plasmodium falciparum.
Joshi MB; Lin DT; Chiang PH; Goldman ND; Fujioka H; Aikawa M; Syin C
Mol Biochem Parasitol; 1999 Mar; 99(1):11-9. PubMed ID: 10215020
[TBL] [Abstract][Full Text] [Related]
28. 4,9-Diaminoacridines and 4-Aminoacridines as Dual-Stage Antiplasmodial Hits.
Fonte M; Tassi N; Fontinha D; Bouzón-Arnáiz I; Ferraz R; Araújo MJ; Fernàndez-Busquets X; Prudêncio M; Gomes P; Teixeira C
ChemMedChem; 2021 Mar; 16(5):788-792. PubMed ID: 33217195
[TBL] [Abstract][Full Text] [Related]
29. Identification of novel quinazoline derivatives as potent antiplasmodial agents.
Bouchut A; Rotili D; Pierrot C; Valente S; Lafitte S; Schultz J; Hoglund U; Mazzone R; Lucidi A; Fabrizi G; Pechalrieu D; Arimondo PB; Skinner-Adams TS; Chua MJ; Andrews KT; Mai A; Khalife J
Eur J Med Chem; 2019 Jan; 161():277-291. PubMed ID: 30366254
[TBL] [Abstract][Full Text] [Related]
30. Ex vivo activity of histone deacetylase inhibitors against multidrug-resistant clinical isolates of Plasmodium falciparum and P. vivax.
Marfurt J; Chalfein F; Prayoga P; Wabiser F; Kenangalem E; Piera KA; Fairlie DP; Tjitra E; Anstey NM; Andrews KT; Price RN
Antimicrob Agents Chemother; 2011 Mar; 55(3):961-6. PubMed ID: 21135175
[TBL] [Abstract][Full Text] [Related]
31. Antimalarial histone deacetylase inhibitors containing cinnamate or NSAID components.
Wheatley NC; Andrews KT; Tran TL; Lucke AJ; Reid RC; Fairlie DP
Bioorg Med Chem Lett; 2010 Dec; 20(23):7080-4. PubMed ID: 20951583
[TBL] [Abstract][Full Text] [Related]
32. Design and synthesis of novel and highly-active pan-histone deacetylase (pan-HDAC) inhibitors.
Tashima T; Murata H; Kodama H
Bioorg Med Chem; 2014 Jul; 22(14):3720-31. PubMed ID: 24864038
[TBL] [Abstract][Full Text] [Related]
33. QSAR Classification Models for Prediction of Hydroxamate Histone Deacetylase Inhibitor Activity against Malaria Parasites.
Hesping E; Chua MJ; Pflieger M; Qian Y; Dong L; Bachu P; Liu L; Kurz T; Fisher GM; Skinner-Adams TS; Reid RC; Fairlie DP; Andrews KT; Gorse AJP
ACS Infect Dis; 2022 Jan; 8(1):106-117. PubMed ID: 34985259
[TBL] [Abstract][Full Text] [Related]
34. Discovery of meta-sulfamoyl N-hydroxybenzamides as HDAC8 selective inhibitors.
Zhao C; Zang J; Ding Q; Inks ES; Xu W; Chou CJ; Zhang Y
Eur J Med Chem; 2018 Apr; 150():282-291. PubMed ID: 29533873
[TBL] [Abstract][Full Text] [Related]
35. Potent antimalarial activity of histone deacetylase inhibitor analogues.
Andrews KT; Tran TN; Lucke AJ; Kahnberg P; Le GT; Boyle GM; Gardiner DL; Skinner-Adams TS; Fairlie DP
Antimicrob Agents Chemother; 2008 Apr; 52(4):1454-61. PubMed ID: 18212103
[TBL] [Abstract][Full Text] [Related]
36. 4-Nitro styrylquinoline is an antimalarial inhibiting multiple stages of Plasmodium falciparum asexual life cycle.
Roberts BF; Zheng Y; Cleaveleand J; Lee S; Lee E; Ayong L; Yuan Y; Chakrabarti D
Int J Parasitol Drugs Drug Resist; 2017 Apr; 7(1):120-129. PubMed ID: 28285258
[TBL] [Abstract][Full Text] [Related]
37. Probing the Azaaurone Scaffold against the Hepatic and Erythrocytic Stages of Malaria Parasites.
Carrasco MP; Machado M; Gonçalves L; Sharma M; Gut J; Lukens AK; Wirth DF; André V; Duarte MT; Guedes RC; Dos Santos DJ; Rosenthal PJ; Mazitschek R; Prudêncio M; Moreira R
ChemMedChem; 2016 Oct; 11(19):2194-2204. PubMed ID: 27538856
[TBL] [Abstract][Full Text] [Related]
38. Ivermectin Impairs the Development of Sexual and Asexual Stages of Plasmodium falciparum
de Carvalho LP; Sandri TL; José Tenório de Melo E; Fendel R; Kremsner PG; Mordmüller B; Held J
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31109978
[TBL] [Abstract][Full Text] [Related]
39. Identification and characterization of small molecule inhibitors of a class I histone deacetylase from Plasmodium falciparum.
Patel V; Mazitschek R; Coleman B; Nguyen C; Urgaonkar S; Cortese J; Barker RH; Greenberg E; Tang W; Bradner JE; Schreiber SL; Duraisingh MT; Wirth DF; Clardy J
J Med Chem; 2009 Apr; 52(8):2185-7. PubMed ID: 19317450
[TBL] [Abstract][Full Text] [Related]
40. Fast-Acting Small Molecules Targeting Malarial Aspartyl Proteases, Plasmepsins, Inhibit Malaria Infection at Multiple Life Stages.
Singh S; Rajendran V; He J; Singh AK; Achieng AO; Vandana ; Pant A; Nasamu AS; Pandit M; Singh J; Quadiri A; Gupta N; Poonam ; Ghosh PC; Singh BK; Narayanan L; Kempaiah P; Chandra R; Dunn BM; Pandey KC; Goldberg DE; Singh AP; Rathi B
ACS Infect Dis; 2019 Feb; 5(2):184-198. PubMed ID: 30554511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
